Cortical thinning related to periventricular and deep white matter hyperintensities

Neurobiology of Aging

Volumn 33, Issue 7, 2012, Pages

  Seo, Sang Won ^a   Lee, Jong Min ^b   Im, Kiho ^c   Park, Jun Sung ^c   Kim, Sook Hui ^d   Kim, Sung Tae ^a   Ahn, Hyun Jung ^a   Chin, Juhee ^a   Cheong, Hae Kwan ^a   Weiner, Michael W ^e   Na, Duk L ^a  

^a Sungkyunkwan University School of Medicine   (South Korea)

^b Hanyang University   (South Korea)

^c BOSTON CHILDREN S HOSPITAL   (United States)

^d Konkuk University Hospital   (South Korea)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

Cognitive impairment; Cortical thickness; Deep white matter hyperintensities; Dementia; Mild cognitive impairment; Periventricle white matter hyperintensities; White matter hyperintensities

Indexed keywords

ADULT; AGED; ALZHEIMER DISEASE; AMNESIA; ARTICLE; BRAIN CORTEX ATROPHY; BRAIN REGION; BRAIN SIZE; DEEP WHITE MATTER HYPERINTENSITY; DISEASE ASSOCIATION; FEMALE; FRONTAL CORTEX; HUMAN; MAJOR CLINICAL STUDY; MALE; MILD COGNITIVE IMPAIRMENT; MULTIINFARCT DEMENTIA; NERVOUS SYSTEM PARAMETERS; NEUROPSYCHOLOGICAL TEST; NUCLEAR MAGNETIC RESONANCE IMAGING; PERIVENTRICULAR WHITE MATTER HYPERINTENSITY; PRIORITY JOURNAL; SUPRASYLVIAN GYRUS; TOPOGRAPHY; WHITE MATTER;

EID: 84861191324     PISSN: 01974580     EISSN: 15581497     Source Type: Journal    
DOI: 10.1016/j.neurobiolaging.2010.12.003     Document Type: Article

References (55)

1. Bombois S., Debette S., Delbeuck X., Bruandet A., Lepoittevin S., Delmaire C., Leys D., Pasquier F. Prevalence of subcortical vascular lesions and association with executive function in mild cognitive impairment subtypes. Stroke 2007, 38:2595-2597.
2. Bowler J.V., Munoz D.G., Merskey H., Hachinski V. Factors affecting the age of onset and rate of progression of Alzheimer's disease. J. Neurol. Neurosurg. Psychiatry 1998, 65:184-190.
3. Braak H., Braak E. Neuropathological staging of Alzheimer-related changes. Acta Neuropathol 1991, 82:239-259.
4. Brickman A.M., Siedlecki K.L., Muraskin J., Manly J.J., Luchsinger J.A., Yeung L.K., Brown T.R., Decarli C., Stern Y. White matter hyperintensities and cognition: Testing the reserve hypothesis. Neurobiol. Aging 2009 Nov 17 2009, [Epub ahead of print].
5. Collins D.L., Neelin P., Peters T.M., Evans A.C. Automatic 3D intersubject registration of MR volumetric data in standardized Talairach space. J. Comput. Assist. Tomogr 1994, 18:192-205.
6. Cummings J.L. Frontal-subcortical circuits and human behavior. Arch. Neurol 1993, 50:873-880.
7. de Groot J.C., de Leeuw F.E., Oudkerk M., van Gijn J., Hofman A., Jolles J., Breteler M.M. Cerebral white matter lesions and cognitive function: the Rotterdam Scan Study. Ann. Neurol 2000, 47:145-151.
8. De Groot J.C., De Leeuw F.E., Oudkerk M., Van Gijn J., Hofman A., Jolles J., Breteler M.M. Periventricular cerebral white matter lesions predict rate of cognitive decline. Ann. Neurol 2002, 52:335-341.
9. Debette S., Bombois S., Bruandet A., Delbeuck X., Lepoittevin S., Delmaire C., Leys D., Pasquier F. Subcortical hyperintensities are associated with cognitive decline in patients with mild cognitive impairment. Stroke 2007, 38:2924-2930.
10. DeCarli C., Fletcher E., Ramey V., Harvey D., Jagust W.J. Anatomical mapping of white matter hyperintensities (WMH): exploring the relationships between periventricular WMH, deep WMH, and total WMH burden. Stroke 2005, 36:50-55.
11. Du A.T., Schuff N., Chao L.L., Kornak J., Ezekiel F., Jagust W.J., Kramer J.H., Reed B.R., Miller B.L., Norman D., Chui H.C., Weiner M.W. White matter lesions are associated with cortical atrophy more than entorhinal and hippocampal atrophy. Neurobiol. Aging 2005, 26:553-559.
12. Erkinjuntti T., Inzitari D., Pantoni L., Wallin A., Scheltens P., Rockwood K., Roman G.C., Chui H., Desmond D.W. Research criteria for subcortical vascular dementia in clinical trials. J. Neural Transm. Suppl 2000, 59:23-30.
13. Fazekas F., Chawluk J.B., Alavi A., Hurtig H.I., Zimmerman R.A. MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging. AJR Am. J. Roentgenol 1987, 149:351-356.
14. Fein G., Di Sclafani V., Tanabe J., Cardenas V., Weiner M.W., Jagust W.J., Reed B.R., Norman D., Schuff N., Kusdra L., Greenfield T., Chui H. Hippocampal and cortical atrophy predict dementia in subcortical ischemic vascular disease. Neurology 2000, 55:1626-1635.
15. Frisoni G.B., Galluzzi S., Bresciani L., Zanetti O., Geroldi C. Mild cognitive impairment with subcortical vascular features: clinical characteristics and outcome. J. Neurol 2002, 249:1423-1432.
16. Galluzzi S., Sheu C.F., Zanetti O., Frisoni G.B. Distinctive clinical features of mild cognitive impairment with subcortical cerebrovascular disease. Dement. Geriatr. Cogn. Disord 2005, 19:196-203.
17. Genovese C.R., Lazar N.A., Nichols T. Thresholding of statistical maps in functional neuroimaging using the false discovery rate. Neuroimage 2002, 15:870-878.
18. Ginsberg S.D., Martin L.J. Axonal transection in adult rat brain induces transsynaptic apoptosis and persistent atrophy of target neurons. J. Neurotrauma 2002, 19:99-109.
19. Im K., Lee J.M., Lee J., Shin Y.W., Kim I.Y., Kwon J.S., Kim S.I. Gender difference analysis of cortical thickness in healthy young adults with surface-based methods. Neuroimage 2006, 31:31-38.
20. Im K., Lee J.M., Yoon U., Shin Y.W., Hong S.B., Kim I.Y., Kwon J.S., Kim S.I. Fractal dimension in human cortical surface: multiple regression analysis with cortical thickness, sulcal depth, and folding area. Hum. Brain Mapp 2006, 27:994-1003.
21. Jagust W.J., Zheng L., Harvey D.J., Mack W.J., Vinters H.V., Weiner M.W., Ellis W.G., Zarow C., Mungas D., Reed B.R., Kramer J.H., Schuff N., DeCarli C., Chui H.C. Neuropathological basis of magnetic resonance images in aging and dementia. Ann. Neurol 2008, 63:72-80.
22. Johnson H., Cowey A. Transneuronal retrograde degeneration of retinal ganglion cells following restricted lesions of striate cortex in the monkey. Exp. Brain Res 2000, 132:269-275.
23. Kim H., Na D.L. Normative data on the Korean version of the Boston Naming Test. J. Clin. Exp. Neuropsychol 1999, 21:127-133.
24. Kim J.S., Singh V., Lee J.K., Lerch J., Ad-Dab'Bagh Y., MacDonald D., Lee J.M., Kim S.I., Evans A.C. Automated 3-D extraction and evaluation of the inner and outer cortical surfaces using a Laplacian map and partial volume effect classification. Neuroimage 2005, 27:210-221.
25. Knopman D.S., Mosley T.H., Catellier D.J., Sharrett A.R. Cardiovascular risk factors and cerebral atrophy in a middle-aged cohort. Neurology 2005, 65:876-881.
26. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969, 9:179-186.
27. Lee J.H., Olichney J.M., Hansen L.A., Hofstetter C.R., Thal L.J. Small concomitant vascular lesions do not influence rates of cognitive decline in patients with Alzheimer disease. Arch. Neurol 2000, 57:1474-1479.
28. Lim A., Tsuang D., Kukull W., Nochlin D., Leverenz J., McCormick W., Bowen J., Teri L., Thompson J., Peskind E.R., Raskind M., Larson E.B. Clinico-neuropathological correlation of Alzheimer's disease in a community-based case series. J. Am. Geriatr. Soc 1999, 47:564-569.
29. Lyttelton O., Boucher M., Robbins S., Evans A. An unbiased iterative group registration template for cortical surface analysis. Neuroimage 2007, 34:1535-1544.
30. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984, 34:939-944.
31. Morris J.C., Storandt M., Miller J.P., McKeel D.W., Price J.L., Rubin E.H., Berg L. Mild cognitive impairment represents early-stage Alzheimer disease. Arch. Neurol 2001, 58:397-405.
32. Mungas D., Jagust W.J., Reed B.R., Kramer J.H., Weiner M.W., Schuff N., Norman D., Mack W.J., Willis L., Chui H.C. MRI predictors of cognition in subcortical ischemic vascular disease and Alzheimer's disease. Neurology 2001, 57:2229-2235.
33. Mungas D., Reed B.R., Jagust W.J., DeCarli C., Mack W.J., Kramer J.H., Weiner M.W., Schuff N., Chui H.C. Volumetric MRI predicts rate of cognitive decline related to AD and cerebrovascular disease. Neurology 2002, 59:867-873.
34. Pantel J., Schroder J., Essig M., Jauss M., Schneider G., Eysenbach K., von Kummer R., Baudendistel K., Schad L.R., Knopp M.V. In vivo quantification of brain volumes in subcortical vascular dementia and Alzheimer's disease. An MRI-based study. Dement. Geriatr. Cogn. Disord 1998, 9:309-316.
35. Petersen R.C., Smith G.E., Waring S.C., Ivnik R.J., Tangalos E.G., Kokmen E. Mild cognitive impairment: clinical characterization and outcome. Arch. Neurol 1999, 56:303-308.
36. Preul C., Lohmann G., Hund-Georgiadis M., Guthke T., von Cramon D.Y. Morphometry demonstrates loss of cortical thickness in cerebral microangiopathy. J. Neurol 2005, 252:441-447.
37. Roman G.C., Erkinjuntti T., Wallin A., Pantoni L., Chui H.C. Subcortical ischaemic vascular dementia. Lancet Neurol 2002, 1:426-436.
38. Sabri O., Ringelstein E.B., Hellwig D., Schneider R., Schreckenberger M., Kaiser H.J., Mull M., Buell U. Neuropsychological impairment correlates with hypoperfusion and hypometabolism but not with severity of white matter lesions on MRI in patients with cerebral microangiopathy. Stroke 1999, 30:556-566.
39. Sachdev P., Wen W., Shnier R., Brodaty H. Cerebral blood volume in T2-weighted white matter hyperintensities using exogenous contrast based perfusion MRI. J. Neuropsychiatry Clin. Neurosci 2004, 16:83-92.
40. Schallert T., Jones T.A., Lindner M.D. Multilevel transneuronal degeneration after brain damage. Behavioral events and effects of anticonvulsant gamma-aminobutyric acid-related drugs. Stroke 1990, 21:143-146.
41. Scheltens P., Barkhof F., Leys D., Pruvo J.P., Nauta J.J., Vermersch P., Steinling M., Valk J. A semiquantitative rating scale for the assessment of signal hyperintensities on magnetic resonance imaging. J. Neurol. Sci 1993, 114:7-12.
42. Selden N.R., Gitelman D.R., Salamon-Murayama N., Parrish T.B., Mesulam M.M. Trajectories of cholinergic pathways within the cerebral hemispheres of the human brain. Brain 1998, 121:2249-2257.
43. Seo S.W., Ahn J., Yoon U., Im K., Lee J.M., Tae-Kim S., Ahn H.J., Chin J., Jeong Y., Na D.L. Cortical Thinning in Vascular Mild Cognitive Impairment and Vascular Dementia of Subcortical Type. J. Neuroimaging 2010, 20:37-45.
44. Seo S.W., Cho S.S., Park A., Chin J., Na D.L. Subcortical vascular versus amnestic mild cognitive impairment: comparison of cerebral glucose metabolism. J. Neuroimaging 2009, 19:213-219.
45. Seo S.W., Im K., Lee J.M., Kim Y.H., Kim S.T., Kim S.Y., Yang D.W., Kim S.I., Cho Y.S., Na D.L. Cortical thickness in single-versus multiple-domain amnestic mild cognitive impairment. Neuroimage 2007, 36:289-297.
46. Sled J.G., Zijdenbos A.P., Evans A.C. A nonparametric method for automatic correction of intensity nonuniformity in MRI data. IEEE Trans. Med. Imaging 1998, 17:87-97.
47. Smith E.E., Egorova S., Blacker D., Killiany R.J., Muzikansky A., Dickerson B.C., Tanzi R.E., Albert M.S., Greenberg S.M., Guttmann C.R. Magnetic resonance imaging white matter hyperintensities and brain volume in the prediction of mild cognitive impairment and dementia. Arch. Neurol 2008, 65:94-100.
48. Snowdon D.A., Greiner L.H., Mortimer J.A., Riley K.P., Greiner P.A., Markesbery W.R. Brain infarction and the clinical expression of Alzheimer disease. The Nun Study. JAMA 1997, 277:813-817.
49. Tierney M.C., Black S.E., Szalai J.P., Snow W.G., Fisher R.H., Nadon G., Chui H.C. Recognition memory and verbal fluency differentiate probable Alzheimer disease from subcortical ischemic vascular dementia. Arch. Neurol 2001, 58:1654-1659.
50. Tomimoto H., Ohtani R., Shibata M., Nakamura N., Ihara M. Loss of cholinergic pathways in vascular dementia of the Binswanger type. Dement. Geriatr. Cogn. Disord 2005, 19:282-288.
51. Tullberg M., Fletcher E., DeCarli C., Mungas D., Reed B.R., Harvey D.J., Weiner M.W., Chui H.C., Jagust W.J. White matter lesions impair frontal lobe function regardless of their location. Neurology 2004, 63:246-253.
52. van den Heuvel D.M., ten Dam V.H., de Craen A.J., Admiraal-Behloul F., Olofsen H., Bollen E.L., Jolles J., Murray H.M., Blauw G.J., Westendorp R.G., van Buchem M.A. Increase in periventricular white matter hyperintensities parallels decline in mental processing speed in a non-demented elderly population. J. Neurol. Neurosurg., Psychiatry 2006, 77:149-153.
53. Wen W., Sachdev P.S., Chen X., Anstey K. Gray matter reduction is correlated with white matter hyperintensity volume: a voxel-based morphometric study in a large epidemiological sample. Neuroimage 2006, 29:1031-1039.
54. Winblad B., Palmer K., Kivipelto M., Jelic V., Fratiglioni L., Wahlund L.O., Nordberg A., Backman L., Albert M., Almkvist O., Arai H., Basun H., Blennow K., deLeon M., De Carli C., Erkinjuntti T., Giacobini E., Graff C., Hardy J., Jack C., Jorm A., Ritchie K., van Duijn C., Visser P., Petersen R.C. Mild cognitive impairment-beyond controversies, towards a consensus: report of the International Working Group on Mild Cognitive Impairment. J. Intern. Med 2004, 256:240-246.
55. Zijdenbos A.P., Evans A.C., Riahi F., Sled J.G., Chui J. Automatic quantification of multiple sclerosis lesion volume using streotaxic space. Proceedings, 4th International Conference on Visualization in Biomed. Computing VBC, Lecture Notes in Computer Science 1996, 1131:439-448. V., K.